Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 11, Issue 523, Pages eaaw1565
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-12-19
DOI
10.1126/scitranslmed.aaw1565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity
- (2018) Alessandra Ventura et al. CANCER RESEARCH
- Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
- (2018) Mary G. Prieve et al. MOLECULAR THERAPY
- Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance
- (2018) Xiang Ling et al. NANO LETTERS
- Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy
- (2018) Sang Chul Lee et al. Cancer Research and Treatment
- Combinatorial programming of human neuronal progenitors using magnetically-guided stoichiometric mRNA delivery
- (2018) Sayyed M Azimi et al. eLife
- Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics
- (2018) Wei Tao et al. ADVANCED MATERIALS
- Abstract CT068: Phase Ib/II combination study of APR-246 and azacitidine (AZA) in patients withTP53mutant myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
- (2018) David A. Sallman et al. CANCER RESEARCH
- Biomedical applications of mRNA nanomedicine
- (2018) Qingqing Xiong et al. Nano Research
- NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer
- (2018) Zhixiong Chen et al. PROSTATE
- Redox-Responsive Nanoparticle-Mediated Systemic RNAi for Effective Cancer Therapy
- (2018) Xiaoding Xu et al. Small
- Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA
- (2018) Mohammad Ariful Islam et al. Nature Biomedical Engineering
- A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours
- (2018) Vincent A. de Weger et al. BRITISH JOURNAL OF CANCER
- Molecular basis of USP7 inhibition by selective small-molecule inhibitors
- (2017) Andrew P. Turnbull et al. NATURE
- Challenges in the gene therapy commercial ecosystem
- (2017) Rahul Kapoor et al. NATURE BIOTECHNOLOGY
- Systemic delivery of factor IX messenger RNA for protein replacement therapy
- (2017) Suvasini Ramaswamy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
- (2017) Xi Zhu et al. Theranostics
- Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
- (2017) Ding An et al. Cell Reports
- Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA
- (2017) Eva Schrom et al. Molecular Therapy-Nucleic Acids
- Tools for translation: non-viral materials for therapeutic mRNA delivery
- (2017) Khalid A. Hajj et al. Nature Reviews Materials
- Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
- (2016) Jason B. Miller et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study
- (2016) Kathleen F Pirollo et al. MOLECULAR THERAPY
- Bioresponsive materials
- (2016) Yue Lu et al. Nature Reviews Materials
- Hydrophobic Cysteine Poly(disulfide)-based Redox-Hypersensitive Nanoparticle Platform for Cancer Theranostics
- (2015) Jun Wu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53
- (2015) Shengliang Zhang et al. CANCER RESEARCH
- Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
- (2015) M. Andreeff et al. CLINICAL CANCER RESEARCH
- p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells
- (2015) Mohamad Harajly et al. MOLECULAR AND CELLULAR BIOLOGY
- An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo
- (2015) Bin Li et al. NANO LETTERS
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
- (2015) Xi Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
- (2015) Miles A. Miller et al. Science Translational Medicine
- Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential
- (2015) Santosh Chauhan et al. Nature Communications
- Biomaterials for mRNA delivery
- (2015) Mohammad Ariful Islam et al. Biomaterials Science
- Ultra-High Throughput Synthesis of Nanoparticles with Homogeneous Size Distribution Using a Coaxial Turbulent Jet Mixer
- (2014) Jong-Min Lim et al. ACS Nano
- A dual role of p53 in the control of autophagy
- (2014) Ezgi Tasdemir et al. Autophagy
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- TIGAR Has a Dual Role in Cancer Cell Survival through Regulating Apoptosis and Autophagy
- (2014) J.-M. Xie et al. CANCER RESEARCH
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals
- (2014) Terence O'Reilly et al. Translational Oncology
- Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives
- (2014) Guang-Xia Chen et al. OncoTargets and Therapy
- Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancer
- (2013) B. Besse et al. ANNALS OF ONCOLOGY
- Inflammation, DAMPs, Tumor Development, and Progression: A Vicious Circle Orchestrated by Redox Signaling
- (2013) Patrizia Castellani et al. ANTIOXIDANTS & REDOX SIGNALING
- Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy
- (2013) T. Kimura et al. CANCER RESEARCH
- Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
- (2013) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells
- (2013) David J Panka et al. Molecular Cancer
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
- (2013) X Sui et al. Cell Death & Disease
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
- (2012) Tongyuan Li et al. CELL
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Counteracting Autophagy Overcomes Resistance to Everolimus in Mantle Cell Lymphoma
- (2012) L. Rosich et al. CLINICAL CANCER RESEARCH
- Mass Production and Size Control of Lipid–Polymer Hybrid Nanoparticles through Controlled Microvortices
- (2012) YongTae Kim et al. NANO LETTERS
- Microfluidic technologies for accelerating the clinical translation of nanoparticles
- (2012) Pedro M. Valencia et al. Nature Nanotechnology
- RNA-based vaccines
- (2012) Jeffrey B. Ulmer et al. VACCINE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- p53 signaling and autophagy in cancer: A revolutionary strategy could be developed for cancer treatment
- (2011) Xinbing Sui et al. Autophagy
- Redox-responsive nanocapsules for intracellular protein delivery
- (2011) Muxun Zhao et al. BIOMATERIALS
- Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery
- (2011) Ru Cheng et al. JOURNAL OF CONTROLLED RELEASE
- Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
- (2011) Michael S D Kormann et al. NATURE BIOTECHNOLOGY
- The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise
- (2011) A. Mandinova et al. Science Translational Medicine
- Mechanisms of mTOR inhibitor resistance in cancer therapy
- (2011) Jennifer S. Carew et al. Targeted Oncology
- Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung Cancer
- (2010) A. Tarhini et al. CLINICAL CANCER RESEARCH
- Translating p53 into the clinic
- (2010) Chit Fang Cheok et al. Nature Reviews Clinical Oncology
- mTOR signaling and drug development in cancer
- (2010) Janet Dancey Nature Reviews Clinical Oncology
- Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells
- (2010) Nathalie Carayol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduction-sensitive polymers and bioconjugates for biomedical applications
- (2009) Fenghua Meng et al. BIOMATERIALS
- AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001
- (2009) M. Marinov et al. CLINICAL CANCER RESEARCH
- Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non-Small Cell Lung Cancer
- (2009) A. Yoshizawa et al. CLINICAL CANCER RESEARCH
- Modulation of intracellular ROS levels by TIGAR controls autophagy
- (2009) Karim Bensaad et al. EMBO JOURNAL
- Cytoplasmic functions of the tumour suppressor p53
- (2009) Douglas R. Green et al. NATURE
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Ark floats gene therapy's boat, for now
- (2008) Randy Osborne NATURE BIOTECHNOLOGY
- Regulation of autophagy by cytoplasmic p53
- (2008) Ezgi Tasdemir et al. NATURE CELL BIOLOGY
- BCL-2 family antagonists for cancer therapy
- (2008) Guillaume Lessene et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation